Neoadjuvant Treatment for Rectal Carcinoma: Is It Still a Challenge?

来源 :BITs 3rd Annual World Cancer Congress-2012(2012第五届世界癌症大会) | 被引量 : 0次 | 上传用户:gameryufei
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Preoperative 5-fluorouracil-based chemoradiotherapy (CRT) and total mesorectal excision surgery have led to a reduction in local recurrence rates being nowadays less than 10%.But despite this great information, the development of distant metastases goes on being the most frequent location of failure (25-30%).Newer generation chemotherapeutics,such as oral fluoropyrimidines, oxaliplatin, irinotecan, and targeted therapies, such as bevacizumab and cetuximab,have been incorporated into phase Ⅰ-Ⅱ studies with preoperative RT for rectal cancer but phase Ⅲ trials are still needed to determine if these drugs will offer an advantage compared with 5-fluorouracil-based combined modality regimen.Early results from the ACCORD 12/0405-Prodige 2 and STAR-01 trial did not confirm a significant improvement of important endpoints, such as the pCR rate, with the addition of oxaliplatin to preoperative 5-fluorouracil based CRT,although long-term results are awaited.Thus, the neoadjuvant treatment for rectal cancer is still challenging and according to several aspects it is controversial.We have carried out a project to clear up these points.
其他文献
A polymorphism at codon 72 of the p53 tumor suppressor gene is a possible determinant for cancer risk, particularly for carcinomas associated with HPV infection.We recently reported that high-risk HPV
会议
Metastatic tumors are the most common intra-ocular malignancies and choroid is by far the most common site for intra-ocular malignancies.Multiple foci are usually involved, and bilateral involvement i
会议
Introduction: Targeted therapy is going to be the mainstay treatment of cancer diseases.In the recent years, the utilization of geftinib, erlotinib and bevacizuamb on metastatic or unresectable non-sm
会议
Carcinoma of the lung is the leading cause of death from malignancy in the United States.Twenty percent of patients with lung carcinoma are asymptomatic early in the course of the disease.Survival rat
会议
Radiofrequency ablation (RFA) uses an electromagnetic wave with a frequency band and is a new treatment offered as a minimally invasive treatment.RFA is most commonly used to treat patients with liver
会议
Late diagnosis and inadequate knowledge about tumor progression and its associated molecular alterations pose significant problems in the treatment of lung cancer patients.To this end, appropriate ani
会议
Treatment options for early-stage prostate cancer are well defined, and localized prostate cancer can be cured by several therapeutic strategies.However, the outcome is still disappointing in advanced
会议
Current treatment of prostate cancer includes surgery, radiation therapy, and hormone therapy.These methods are only effective for some patients but with strong side effects, such as much reduced sexu
会议
Aim: To assess the overall impact of the most common contemporary prostate cancer therapies (radical prostatectomy,percutaneous irradiation, brachytherapy, hormonal therapy) with regard to physical an
会议
Background : Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant disorder predisposing humans to cutaneous and uterine leiomyomas;in 20% of affected families, type 2 papil
会议